News
News
- CORRECTION: BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures
00:58 - GlobeNewswire - BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures
11/16/2019 / 23:30 - GlobeNewswire - Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
11/16/2019 / 18:00 - GlobeNewswire - Colchicine significantly reduces the risk of first and total ischemic cardiovascular events by 23% and 34% respectively in addition to standard of care in patients with a recent myocardial infarction (MI)
11/16/2019 / 17:03 - GlobeNewswire - Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes Trial
11/14/2019 / 23:34 - GlobeNewswire - Philips announces first installation of IntelliSpace Critical Care and Anesthesia system at Kasih Ibu Hospital in Bali, Indonesia
11/14/2019 / 10:00 - GlobeNewswire - Curetis Provides Business Update for the First Nine Months of 2019
11/14/2019 / 08:00 - GlobeNewswire - Henkel posts 9.43% lower net income in Q3
11/14/2019 / 07:35 - TeleTrader - Somml Connex Revolutionizes Health Care Experience for Patients, Providers, and Caregivers
11/13/2019 / 12:00 - GlobeNewswire - Study Reveals an Exclusive Human Milk Diet With Prolact+ H2MF, Prolacta’s 100% Breastmilk-Based Fortifier, Substantially Reduces Costs Due to Complications in the NICU
11/12/2019 / 15:05 - GlobeNewswire
Real-time